Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL4256892

N.NC(=O)c1oc2c(O)cccc2c1Br

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 9/20 0.41
EGFR P00533 1/20 0.41
LCK P06239 1/20 0.41
ATP1A1 P05023 2/20 0.41
ATP1B1 P05026 2/20 0.41
ATP1A3 P13637 2/20 0.41
ATP1B2 P14415 2/20 0.41
ATP1A2 P50993 2/20 0.41
ATP1B3 P54709 2/20 0.41
FXYD2 P54710 2/20 0.41
ATP1A4 Q13733 2/20 0.41
LOXL2 Q9Y4K0 1/20 0.40
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 3/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MCL1 Q07820 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL4256896 0.79 KDM4E (0.43) MAOAEGFRLCKATP1A1ATP1B1
SCHEMBL28290291 0.75 MAOA (0.50) MAOAEGFRLCKATP1A1ATP1B1
SCHEMBL6382634 0.73 ALDH1A1 (0.53) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL10846874 0.73 MAOA (0.50) MAOAEGFRATP1A1ATP1B1ATP1A3
SCHEMBL10790821 0.69 KDM4E (0.51) MAOAEGFRATP1A1ATP1B1ATP1A3
SCHEMBL19743717 0.68 LOXL2 (0.57) MAOAEGFRLCKATP1A1ATP1B1
SCHEMBL5141096 0.68 ATP1A1 (0.59) MAOAEGFRATP1A1ATP1B1ATP1A3
SCHEMBL13699871 0.67 MAPT (0.68) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL24343644 0.66 ATP1A1 (0.49) MAOAEGFRATP1A1ATP1B1ATP1A3
SCHEMBL11127156 0.66 MCL1 (0.57) KDM4EL3MBTL1ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1710233-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F MAOA 240/4885EGFR 2944/4885LCK 4589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.